Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

It offers a variety of products, including faux wood, cellular, mini, vertical, vinyl and wood blinds. Shades are also ... Design consultations are free, and your sales professional will show ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

On the downside, smartphone-app-based mapping doesn’t do so great when you don’t have a cellular signal ... The Technology trim also adds blind spot monitoring. A backup camera is now standard ...

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

Maintaining healthy blood sugar levels is an essential aspect of overall wellness, especially for those who struggle with ...

The global window coverings market is estimated to be valued at USD 23 billion in 2023 and is projected to reach USD 35 ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) to Johnson & Johnson for $132.00 per share in cash is fair to ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) to Johnson & Johnson for $132.00 per share in cash is fair to ...

To find out which TVs are easiest to use and watch for people with sight issues, we developed an accessibility test in partnership with the Royal National Institute of Blind People (RNIB). The new ...

The crash claimed the life of Nicholas Barron, 30, of Lafayette.

Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intra-Cellular Therapies, Inc. (NasdaqGS: ITCI) to Johnson & Johnson (NYSE ...